Follow-ups of metabolic, inflammatory and oxidative stress markers, and brachial-ankle pulse wave velocity in middle-aged subjects without metabolic syndrome

Clinical and Experimental Hypertension

Volumn 35, Issue 5, 2013, Pages 382-388

  Kim, Oh Yoen ^a   Paik, Jean Kyung ^b   Lee, Ju Young ^c   Lee, Sang Hyun ^d   Lee, Jong Ho ^c  

^a Dong A University   (South Korea)

^b Eulji University   (South Korea)

^c Yonsei University   (South Korea)

^d National Health Insurance Corporation   (South Korea)

Author keywords

Brachial ankle pulse wave velocity; Inflammatory; MetS; Oxidative stress markers

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEUKOCYTE COUNT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PULSE WAVE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84884995350     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.739232     Document Type: Article

References (32)

1. Scuteri A, Orru M, Morrell C, et al. Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA study. Atherosclerosis 2011; 215:459-464.
2. Scuteri A, Najjar SS, Muller DC, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004; 43:1388-1395.
3. Tomiyama H, Hirayama Y, Hashimoto H, et al. The effects of changes in the metabolic syndrome detection status on arterial stiffening: a prospective study. Hypertens Res 2006; 29(9): 673-678.
4. Safar ME, Thomas F, Blacher J, et al. Metabolic syndrome and age-related progression of aortic stiffness. J AmColl Cardiol 2006; 47(1):72-75.
5. Grundy SM. Inflammation, hypertension, and the metabolic syndrome. J Am Med Assoc 2003; 290:3000-3002.
6. Kampus P, Muda P, Kals J, et al. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol 2006; 112:46-51.
7. Kals J, Kampus P, Kals M, et al. Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis. Scand J Clin Lab Invest 2009; 68:594-601.
8. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006; 189:47-60.
9. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004; 344:1-12.
10. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731-733.
11. Brinkley TE, Nicklas BJ, Kanaya AM, et al. Plasma oxidized lowdensity lipoprotein levels and arterial stiffness in older adults: the health, aging, and body composition study. Hypertension 2009; 53:846-852.
12. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study. Diabetes 2001; 50:2384-2389.
13. Hsu PF, Chuang SY, Cheng HM, Tsai ST, Chou P, Chen CH. Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: a community-based study. Diabetes Res Clin Pract 2008; 79:461-467.
14. Lin YC, Hsiao TJ, Chen PC. Persistent rotating shift-work exposure accelerates development of metabolic syndrome among middle-aged female employees: a five-year follow-up. Chronobiol Int 2009; 26:740-755
15. Hung CS, Lin JW, Hsu CN, et al. Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Nutr Metab Cardiovasc Dis 2009; 19:241-246.
16. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 2010; 74:24-33.
17. Tsuchikura S, Shoji T, Kimoto E, et al. Brachial-ankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb 2010; 17:658-665.
18. Lakatta EG, Levy D. Arterial and cardiac aging: major share holders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 2003; 107:139-146.
19. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003; 107:490-497.
20. Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 2005; 66L:307-317.
21. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50:1-13.
22. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-943.
23. Tso TK, Huang WN, Huang HY, Chang CK. Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus. Lupus 2005; 14(11):878-883.
24. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6 depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83:847-850.
25. Sekitani Y, Hayashida N, Kadota K, et al. White blood cell count and cardiovascular biomarkers of atherosclerosis. Biomarkers 2010; 15:454-460.
26. Lao XQ, Neil Thomas G, Jiang C, et al. White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank cohort study. Atherosclerosis 2008; 201:418-424.
27. Li C, Engström G, Hedblad B. Leukocyte count is associated with incidence of coronary events, but not with stroke: a prospective cohort study. Atherosclerosis 2010; 209:545-550.
28. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. J Am Med Assoc 1985; 254:1932-1937.
29. Fernandez-Real JM, Vayreda M, Richart C, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86:1154-1159.
30. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82:4196- 4200.
31. Wannamethee SG, Whincup PH, Rumley A, Lowe GD. Interrelationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost 2007; 5:1637-1643.
32. Esmaillzadeh A, Azadbakht L. Dietary energy density and the metabolic syndrome among Iranian women. Eur J Clin Nutr 2011; 65(5):598-605.